Life ScienceCompany
Where is CLL Pharma - Opioid Agonist headquartered?
CLL Pharma - Opioid Agonist is headquartered in France.
What sector is CLL Pharma - Opioid Agonist in?
CLL Pharma - Opioid Agonist is a life science company.
CLL Pharma - Opioid Agonist is headquartered in France.
CLL Pharma - Opioid Agonist is a life science company.
CLL Pharma - Opioid Agonist compound called BTG6001, is an orally active opioid agonist with a long duration of action, potentially reducing the amount of analgesic required for effective pain control. Owing to its unique receptor profile, BTG6001 is also expected to show a superior side effect profile compared with current opiate analgesics.
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
